Authors:
Address: Department of Medicine, Georgetown University Hospital, Washington, DC 20016, USA. achester@foxhallinternists.com
Journal:

Publication:

abstract

We describe a Case of a woman who developed a Peripheral polyneuropathy shortly after completing 4 weekly doses of mefloquine hydrochloride (250 mg) malaria prophylaxis. Although mefloquine-related central nervous system neuropathy is well described in the literature, peripheral polyneuropathy similar to this case has been documented only once before, to our knowledge.

Related Articles
Mefloquine toxicity presenting with polyneuropathy - a report of two cases in India.
Trans R Soc Trop Med Hyg. 2006
Mefloquine toxicity presenting with polyneuropathy - a report of two cases in India.
Jha S, Kumar R, Kumar R. Trans R Soc Trop Med Hyg. 2006 Jun; 100(6):594-6. Epub 2005 Oct 20.
A severe adverse reaction to mefloquine and chloroquine prophylaxis.
Aust Fam Physician. 1998
A severe adverse reaction to mefloquine and chloroquine prophylaxis.
Lysack JT, Lysack CL, Kvern BL. Aust Fam Physician. 1998 Dec; 27(12):1119-20.
Mefloquine-induced eosinophilic pneumonia.
Pharmacotherapy. 2007
Mefloquine-induced eosinophilic pneumonia.
Katsenos S, Psathakis K, Nikolopoulou MI, Constantopoulos SH. Pharmacotherapy. 2007 Dec; 27(12):1767-71.
Review Mefloquine for preventing malaria in nonimmune adult travelers.
Am Fam Physician. 2004
Review Mefloquine for preventing malaria in nonimmune adult travelers.
Cayley WE Jr. Am Fam Physician. 2004 Feb 1; 69(3):521-2.
Review Mefloquine and malaria prophylaxis.
Drug Ther Bull. 1998
Review Mefloquine and malaria prophylaxis.
. Drug Ther Bull. 1998 Mar; 36(3):20-2.

To top • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster